Compile Data Set for Download or QSAR
Report error Found 154 Enz. Inhib. hit(s) with all data for entry = 10669
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558701(US11365204, Example 56 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558701(US11365204, Example 56 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558700(US11365204, Example 55 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558700(US11365204, Example 55 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558703(US11365204, Example 58 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558703(US11365204, Example 58 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558702(US11365204, Example 57 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558702(US11365204, Example 57 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558705(US11365204, Example 60 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558705(US11365204, Example 60 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558704(US11365204, Example 59 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558704(US11365204, Example 59 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558707(US11365204, Example 62 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558707(US11365204, Example 62 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558706(US11365204, Example 61 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558706(US11365204, Example 61 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558693(US11365204, Example 48 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558693(US11365204, Example 48 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558692(US11365204, Example 47 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558692(US11365204, Example 47 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558694(US11365204, Example 49 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558694(US11365204, Example 49 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558697(US11365204, Example 52 | O1-methyl O4-[1-[4- [meth...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558697(US11365204, Example 52 | O1-methyl O4-[1-[4- [meth...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558696(US11365204, Example 51 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558696(US11365204, Example 51 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558699(US11365204, Example 54 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558699(US11365204, Example 54 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558698(US11365204, Example 53 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558698(US11365204, Example 53 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558717(US11365204, Example 72 | [1-[4-[[(3S)-1-acetyl- py...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558717(US11365204, Example 72 | [1-[4-[[(3S)-1-acetyl- py...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558719(US11365204, Example 74 | [1-[4-[[(3S)-1-acetyl- py...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558718(US11365204, Example 73 | [1-[4-[[(3S)-1-acetyl- py...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558709(US11365204, Example 67 | [1-[(5R)-4-[methyl- (tetr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558709(US11365204, Example 67 | [1-[(5R)-4-[methyl- (tetr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558708(US11365204, Example 63 | [1-[(5R)-4-[methyl- (tetr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558711(US11365204, Example 66 | [1-[4-(6-oxaspiro[3.3]- h...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558711(US11365204, Example 66 | [1-[4-(6-oxaspiro[3.3]- h...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558710(US11365204, Example 65 | [1-[4-(6-oxaspiro[3.3]- h...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558710(US11365204, Example 65 | [1-[4-(6-oxaspiro[3.3]- h...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558713([1-[(5R)-4-(6-oxaspiro- [3.3]heptan-2-ylamino)-5- ...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558713([1-[(5R)-4-(6-oxaspiro- [3.3]heptan-2-ylamino)-5- ...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558709(US11365204, Example 67 | [1-[(5R)-4-[methyl- (tetr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558709(US11365204, Example 67 | [1-[(5R)-4-[methyl- (tetr...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558715(US11365204, Example 71 | [1-[(5R)-4-(6-oxaspiro- [...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558715(US11365204, Example 71 | [1-[(5R)-4-(6-oxaspiro- [...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558656(US11365204, Example 11 | [1-[(5R)-5-oxido-4- (tetr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558656(US11365204, Example 11 | [1-[(5R)-5-oxido-4- (tetr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558657(US11365204, Example 12 | [1-[(5R)-5-oxido-4- (tetr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

Displayed 1 to 50 (of 154 total ) | Next | Last >>
Jump to: